Linvoseltamab (Anti-BCMA & CD3)
Product Specifications
CAS Number
2408319-25-3
Synonyms
REGN5458
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Linvoseltamab is a human bispecific T-cell engager (BiTE) antibody that targets the tumor-associated antigen (TAA) human B-cell maturation antigen (BCMA) and the CD3 antigen on T lymphocytes. It demonstrates significant antitumor activity and high efficacy in patients with late-stage relapsed/refractory multiple myeloma (RRMM) . MW: 145.78 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP304819M 100 µg
RPB11 (POLR2J) (NM_006234) Human Recombinant Protein
Sign In for Pricing
View Details 
BNC042394-500 1x 500 µL
CD25 / IL2RA (Activated Lymphocyte Marker) (IL2RA/2394), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 